# Trevi Therapeutics, Inc.: filings

TRVI · Nasdaq · CIK 1563880 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trvi.md) · [Financials](/companies/trvi/financials.md) · [Filings](/companies/trvi/filings.md) · [Insiders](/companies/trvi/insiders.md)

## Reports and events: 134 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 198, 8-K 80, 3 43, 10-Q 23, SC 13G/A 19, SCHEDULE 13G/A 15, 144 13, SC 13G 12, CORRESP 10, S-8 9, UPLOAD 9, 424B5 8, 4/A 8, 5 8, DEFA14A 8, 10-K 7, DEF 14A 7, EFFECT 7, D 5, S-3 5, SC 13D/A 5, ARS 4, SCHEDULE 13D/A 4, S-1 3, S-1/A 3, SCHEDULE 13G 3, 424B3 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SC 13D 2, 144/A 1, 424B4 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, FWP 1, RW 1, S-3/A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:12 ET | [10-Q](/filings/0001193125-26-338023.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338023 |
| 2026-08-06 | 16:08 ET | [8-K](/filings/0001193125-26-337974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337974 |
| 2026-06-04 | 16:05 ET | [8-K](/filings/0001193125-26-257365.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257365 |
| 2026-05-07 | 18:23 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000382.md) | Ownership report, active investor, amended | 0001072613-26-000382 |
| 2026-05-05 | 16:09 ET | [10-Q](/filings/0001193125-26-206390.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206390 |
| 2026-05-05 | 16:07 ET | [8-K](/filings/0001193125-26-206382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206382 |
| 2026-04-21 | 16:00 ET | [DEF 14A](/filings/0001193125-26-166695.md) | Proxy statement, period 2026-04-21 | 0001193125-26-166695 |
| 2026-04-17 | 08:06 ET | [8-K](/filings/0001193125-26-160355.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-160355 |
| 2026-03-17 | 16:08 ET | [10-K](/filings/0001193125-26-110783.md) | Annual report, period 2025-12-31 | 0001193125-26-110783 |
| 2026-03-17 | 16:07 ET | [8-K](/filings/0001193125-26-110767.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-110767 |
| 2026-03-09 | 16:35 ET | [8-K](/filings/0001193125-26-098676.md) | 8.01 Other events | 0001193125-26-098676 |
| 2026-02-13 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000150.md) | Ownership report, active investor, amended | 0001072613-26-000150 |
| 2025-12-05 | 08:58 ET | [8-K](/filings/0001193125-25-308769.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-308769 |
| 2025-11-13 | 16:09 ET | [10-Q](/filings/0001193125-25-280166.md) | Quarterly report, period 2025-09-30 | 0001193125-25-280166 |
| 2025-11-13 | 16:08 ET | [8-K](/filings/0001193125-25-280149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-280149 |
| 2025-08-20 | 16:31 ET | [8-K](/filings/0001563880-25-000005.md) | 5.02 Departure or appointment of officers or directors | 0001563880-25-000005 |
| 2025-08-11 | 18:56 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000533.md) | Ownership report, active investor, amended | 0001072613-25-000533 |
| 2025-08-07 | 16:19 ET | [10-Q](/filings/0000950170-25-105066.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105066 |
| 2025-08-07 | 16:08 ET | [8-K](/filings/0000950170-25-105011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105011 |
| 2025-06-17 | 17:00 ET | [8-K](/filings/0000950170-25-087486.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-087486 |
| 2025-06-04 | 16:18 ET | [8-K](/filings/0001193125-25-134913.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-134913 |
| 2025-06-02 | 16:02 ET | [8-K](/filings/0001193125-25-133273.md) | 8.01 Other events | 0001193125-25-133273 |
| 2025-06-02 | 09:31 ET | [8-K](/filings/0001193125-25-132890.md) | 8.01 Other events | 0001193125-25-132890 |
| 2025-05-08 | 16:16 ET | [10-Q](/filings/0000950170-25-067011.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067011 |
| 2025-05-08 | 16:12 ET | [8-K](/filings/0000950170-25-066971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066971 |
| 2025-04-29 | 10:14 ET | [DEF 14A](/filings/0000950170-25-059628.md) | Proxy statement, period 2025-04-29 | 0000950170-25-059628 |
| 2025-03-20 | 19:55 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000239.md) | Ownership report, active investor, amended | 0001072613-25-000239 |
| 2025-03-18 | 16:14 ET | [10-K](/filings/0000950170-25-041194.md) | Annual report, period 2024-12-31 | 0000950170-25-041194 |
| 2025-03-18 | 16:10 ET | [8-K](/filings/0000950170-25-041187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-041187 |
| 2025-03-10 | 17:03 ET | [8-K](/filings/0000950170-25-036503.md) | 8.01 Other events | 0000950170-25-036503 |
| 2025-01-08 | 08:00 ET | [8-K](/filings/0000950170-25-003286.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-003286 |
| 2024-12-16 | 17:20 ET | [8-K](/filings/0001193125-24-279715.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-279715 |
| 2024-12-12 | 08:00 ET | [8-K](/filings/0000950170-24-135602.md) | 8.01 Other events | 0000950170-24-135602 |
| 2024-12-03 | 17:20 ET | [8-K](/filings/0000950170-24-132883.md) | 8.01 Other events | 0000950170-24-132883 |
| 2024-11-08 | 18:57 ET | [SC 13D/A](/filings/0001072613-24-000813.md) | Ownership report, active investor, amended | 0001072613-24-000813 |
| 2024-11-06 | 16:20 ET | [10-Q](/filings/0000950170-24-122355.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122355 |
| 2024-11-06 | 16:12 ET | [8-K](/filings/0000950170-24-122316.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122316 |
| 2024-10-21 | 10:43 ET | [8-K](/filings/0000950170-24-115800.md) | 8.01 Other events | 0000950170-24-115800 |
| 2024-10-04 | 08:07 ET | [8-K](/filings/0000950170-24-112729.md) | 8.01 Other events | 0000950170-24-112729 |
| 2024-10-01 | 17:37 ET | [8-K](/filings/0000950170-24-110462.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-110462 |
| 2024-08-08 | 16:13 ET | [10-Q](/filings/0000950170-24-093983.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093983 |
| 2024-08-08 | 16:09 ET | [8-K](/filings/0000950170-24-093942.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093942 |
| 2024-06-13 | 17:01 ET | [8-K](/filings/0000950170-24-073129.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-073129 |
| 2024-05-21 | 18:34 ET | [SC 13D/A](/filings/0001072613-24-000518.md) | Ownership report, active investor, amended | 0001072613-24-000518 |
| 2024-05-07 | 16:11 ET | [10-Q](/filings/0000950170-24-054489.md) | Quarterly report, period 2024-03-31 | 0000950170-24-054489 |
| 2024-05-07 | 16:09 ET | [8-K](/filings/0000950170-24-054478.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054478 |
| 2024-04-26 | 16:38 ET | [DEF 14A](/filings/0000950170-24-049234.md) | Proxy statement, period 2024-06-13 | 0000950170-24-049234 |
| 2024-03-20 | 16:10 ET | [10-K](/filings/0000950170-24-034167.md) | Annual report, period 2023-12-31 | 0000950170-24-034167 |
| 2024-03-20 | 16:08 ET | [8-K](/filings/0000950170-24-034159.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-034159 |
| 2023-11-09 | 16:13 ET | [10-Q](/filings/0000950170-23-062063.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062063 |

Page 1 of 3. [Older](/companies/trvi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.